Susana holds a PhD in Biology and brings over 20 years of executive experience bridging science and business in biotechnology and life sciences. Her career spans business development and leadership roles in biotech and medtech ventures, where she has guided teams through growth, investment, and international expansion.
Oscar is doctor in organic chemistry and chemical engineer. He currently is the Group Leader at the Precision Medicine and Metabolism Laboratory of the CIC bioGUNE, has in-depth expertise in the use of nuclear magnetic resonance (NMR) for the study of biologically relevant proteins and enzymes.
Cristina holds a bachelor’s degree in Pharmacy and a master’s degree in Monitoring and Management of clinical studies. She has more than 13 years of experience in the industry, having participated in clinical developments in different therapeutic areas. She leads the operations of the company focused on the execution of Phase I-II clinical trials.
Anna has extensive management experience in the world of entrepreneurship, innovation, and in high-growth and changing environments. She is currently focused on advising impact startups in early and growth stages on their financing and operations and joined Atlas in 2023. She holds a degree in Economics and Business Sciences from UPF and an MBA from IESE.
Alain holds a dual academic background, with a bachelor’s degree in Biochemistry and a degree in Computer Engineering. He completed his PhD at the University of the Basque Country (UPV/EHU), followed by postdoctoral research at CIC bioGUNE before advancing his career at prestigious German institutions including DZNE and MPI. Alain’s expertise lies at the intersection of structural biology and data analysis, complemented by extensive hands-on experience with various biochemical and biophysical techniques.
Mireia obtained her PhD in Biomedicine from the University of Barcelona. After completing a master’s degree in Clinical Trial Monitoring, she joined ATLAS as an Operations Manager in 2024. She brings her scientific background and clinical research expertise to support the company’s ongoing trial management and strategic operations.
Sarah is pursuing her PhD at ATLAS Molecular Pharma as part of the European Network on the Supramolecular Chemistry of Carbohydrates (ENSCC). She earned her Bachelor’s degree in Chemistry from the University of Vienna and holds Master’s degrees in Technical Chemistry from the Vienna University of Technology and Molecular Biology from the University of Vienna. Her academic and professional journey focuses on organic synthesis, biochemistry, and protein NMR spectroscopy.
Pablo Herrero holds a bachelor’s degree in biology from the University of the Basque Country (UPV/EHU), where he specialized in zoology. He also earned a Higher Technician Diploma in Laboratory Analysis and Quality Control from Jesuitak Politeknikoa Chemistry and Electronics School.
At Atlas Molecular Pharma, Pablo contributes to the cell culture and protein purification areas, supporting the company’s ongoing research and development activities in personalized medicine and biosensors.